Heritage Pharmaceuticals Inc., of Eatontown, N.J., signed an exclusive development, supply and distribution agreement with Dexcel Pharma Ltd., of Or Akiva, Israel, for an undisclosed extended-release abbreviated new drug application product that generates annual U.S. sales of approximately $60 million.